{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:51:40Z","timestamp":1791834700806,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12026-7","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:14:27Z","timestamp":1763136867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of fluoroquinolone-resistant enterobacterales colonization on fluoroquinolone prophylaxis efficacy in hematopoietic cell transplant recipients"],"prefix":"10.1186","volume":"25","author":[{"given":"Rima","family":"Moghnieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Abdessamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Sfeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mezher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Abi","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Hamade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysar","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Attieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Hneini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Sily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Zorkot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"12026_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.12688\/f1000research.11233.1","volume":"6","author":"M Norkin","year":"2017","unstructured":"Norkin M, Wingard JR. Recent advances in hematopoietic stem cell transplantation. F1000Res. 2017;6:870.","journal-title":"F1000Res"},{"issue":"2","key":"12026_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.idc.2010.01.010","volume":"24","author":"JR Wingard","year":"2010","unstructured":"Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am. 2010;24(2):257\u201372.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"12026_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353(10):977\u201387.","journal-title":"N Engl J Med"},{"issue":"5","key":"12026_CR4","first-page":"1499","volume":"26","author":"SSF Lee","year":"2018","unstructured":"Lee SSF, Fulford AE, Quinn MA, et al. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions. Support Care Cancer. 2018;26(5):1499\u2013504.","journal-title":"Support Care Cancer"},{"issue":"14","key":"12026_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update. J Clin Oncol. 2018;36(14):1443\u201353.","journal-title":"J Clin Oncol"},{"issue":"10","key":"12026_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med. 2005;353(10):988\u201398.","journal-title":"N Engl J Med"},{"issue":"12 Pt 1","key":"12026_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","volume":"142","author":"A Gafter-Gvili","year":"2005","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 2005;142(12 Pt 1):979\u201395.","journal-title":"Ann Intern Med"},{"issue":"3","key":"12026_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbmt.2014.12.006","volume":"21","author":"A Miles-Jay","year":"2015","unstructured":"Miles-Jay A, Butler-Wu S, Rowhani-Rahbar A, Pergam SA. Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of Levofloxacin prophylaxis. Biol Blood Marrow Transpl. 2015;21(3):539\u201345.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"12026_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","volume":"76","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Averbuch D, Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018;76(1):20\u201337.","journal-title":"J Infect"},{"issue":"3","key":"12026_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/313719","volume":"30","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of Ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30(3):473\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12026_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1128\/AAC.49.5.2137-2139.2005","volume":"49","author":"MJ Schwaber","year":"2005","unstructured":"Schwaber MJ, Navon-Venezia S, Schwartz D, et al. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49(5):2137\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"12026_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/322667","volume":"33","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach E, Strom BL, Bilker WB, et al. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2001;33(8):1288\u201394.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"12026_CR13","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/cid\/ciy363","volume":"67","author":"MJ Satlin","year":"2018","unstructured":"Satlin MJ, Chavda KD, Baker TM, et al. Colonization with Levofloxacin-resistant Extended-spectrum \u03b2-Lactamase-producing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2018;67(11):1720\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"12026_CR14","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41409-020-0811-y","volume":"55","author":"A Verlinden","year":"2020","unstructured":"Verlinden A, Mikulska M, Knelange NS, et al. Current antimicrobial practice in febrile neutropenia across Europe and asia: the EBMT infectious disease working party survey. Bone Marrow Transpl. 2020;55(8):1588\u201394.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"12026_CR15","doi-asserted-by":"publisher","first-page":"ofac005","DOI":"10.1093\/ofid\/ofac005","volume":"9","author":"JN Barreto","year":"2022","unstructured":"Barreto JN, Aitken SL, Krantz EM, et al. Variation in clinical practice and attitudes on antibacterial management of fever and neutropenia in patients with hematologic malignancy: A survey of cancer centers across the united States. Open Forum Infect Dis. 2022;9(3):ofac005.","journal-title":"Open Forum Infect Dis"},{"key":"12026_CR16","doi-asserted-by":"publisher","unstructured":"Mona T, Yazdi D, Avula. 1773. Evaluation of fluoroquinolone prophylaxis in preventing bacterial infection in neutropenic afebrile patients without leukemias or HSCT: a systematic review, open forum infectious diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1403. https:\/\/doi.org\/10.1093\/ofid\/ofac492.1403.","DOI":"10.1093\/ofid\/ofac492.1403"},{"issue":"1","key":"12026_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10428194.2010.518655","volume":"52","author":"ES Ng","year":"2011","unstructured":"Ng ES, Liew Y, Earnest A, et al. Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance. Leuk Lymphoma. 2011;52(1):131\u20133.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"12026_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","volume":"24","author":"EJ Bow","year":"2011","unstructured":"Bow EJ. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients. Curr Opin Infect Dis. 2011;24(6):545\u201353.","journal-title":"Curr Opin Infect Dis"},{"key":"12026_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/1471-2334-13-563","volume":"13","author":"FG De Rosa","year":"2013","unstructured":"De Rosa FG, Motta I, Audisio E, et al. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing Levofloxacin prophylaxis. BMC Infect Dis. 2013;13:563.","journal-title":"BMC Infect Dis"},{"key":"12026_CR20","doi-asserted-by":"publisher","unstructured":"Nagler A, Shimoni A, et al. Conditioning. In: Carreras E, Dufour C, Mohty M, editors. The EBMT Handbook: Hematopoietic stem cell transplantation and cellular therapies [Internet]. 7th ed. Cham (CH): Springer; 2019. Chapter 13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553926\/https:\/\/doi.org\/10.1007\/978-3-030-02278-5_13.","DOI":"10.1007\/978-3-030-02278-5_13"},{"key":"12026_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl. 2009;15:1143\u2013238.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"12026_CR22","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56\u201393.","journal-title":"Clin Infect Dis"},{"key":"12026_CR23","volume-title":"Version 1.2022","author":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)","year":"2022","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Prevention and treatment of Cancer-Related infections. Version 1.2022. Fort Washington, PA: National Comprehensive Cancer Network; 2022. https:\/\/www.nccn.org."},{"issue":"7","key":"12026_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/cid\/ciab404","volume":"73","author":"MJ Satlin","year":"2021","unstructured":"Satlin MJ, Chen L, Douglass C, et al. Colonization with fluoroquinolone-Resistant enterobacterales decreases the effectiveness of fluoroquinolone prophylaxis in hematopoietic cell transplant recipients. Clin Infect Dis. 2021;73(7):1257\u201365.","journal-title":"Clin Infect Dis"},{"key":"12026_CR25","doi-asserted-by":"publisher","first-page":"e85210","DOI":"10.1371\/journal.pone.0085210","volume":"9","author":"Y Chong","year":"2014","unstructured":"Chong Y, Shimoda S, Yakushiji H, et al. Clinical impact of fluoroquinolone- resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and Levofloxacin prophylaxis. PLoS ONE. 2014;9:e85210.","journal-title":"PLoS ONE"},{"key":"12026_CR26","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) Dashboard, Country, territory or area profiles. World Health Organ, 2023, https:\/\/worldhealthorg.shinyapps.io\/glass-dashboard\/_w_da287acd\/_w_2724ea81\/#!\/cta-profiles."},{"issue":"Suppl 1","key":"12026_CR27","doi-asserted-by":"publisher","first-page":"e14169","DOI":"10.1111\/tid.14169","volume":"25","author":"LS Gottesdiener","year":"2023","unstructured":"Gottesdiener LS, Satlin MJ. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients. Transpl Infect Dis. 2023;25(Suppl 1):e14169. https:\/\/doi.org\/10.1111\/tid.14169. Epub 2023 Oct 20. PMID: 37864309; PMCID: PMC10844985.","journal-title":"Transpl Infect Dis"},{"key":"12026_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fcimb.2015.00011","volume":"5","author":"R Moghnieh","year":"2015","unstructured":"Moghnieh R, Estaitieh N, Mugharbil A, et al. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Front Cell Infect Microbiol. 2015;5:11.","journal-title":"Front Cell Infect Microbiol"},{"key":"12026_CR29","unstructured":"Moghnieh R, Kanafani ZA, Abi Hanna P, et al. Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. Lebanese Medical Journal 2017;103:1\u201320."},{"issue":"2","key":"12026_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00277-020-04297-8","volume":"100","author":"M Christopeit","year":"2021","unstructured":"Christopeit M, Schmidt-Hieber M, Sprute R, et al. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous Haematopoietic stem cell transplantation. 2020 update of the recommendations of the infectious diseases working party (AGIHO) of the German society of hematology and medical oncology (DGHO). Ann Hematol. 2021;100(2):321\u201336.","journal-title":"Ann Hematol"},{"issue":"1b","key":"12026_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","volume":"41","author":"MA Slavin","year":"2011","unstructured":"Slavin MA, Lingaratnam S, Mileshkin L, et al. Use of antibacterial prophylaxis for patients with neutropenia. Australian consensus guidelines 2011 steering committee. Intern Med J. 2011;41(1b):102\u20139.","journal-title":"Intern Med J"},{"issue":"suppl 5","key":"12026_CR32","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27(suppl 5):v111\u20138.","journal-title":"Ann Oncol"},{"issue":"12","key":"12026_CR33","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S1470-2045(19)30506-6","volume":"20","author":"MT Drayson","year":"2019","unstructured":"Drayson MT, Bowcock S, Planche T, et al. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Oncol. 2019;20(12):1760\u201372.","journal-title":"Lancet Oncol"},{"issue":"12","key":"12026_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.clml.2022.08.001","volume":"22","author":"J Caro","year":"2022","unstructured":"Caro J, Madero-Marroquin R, Zubizarreta N, et al. Impact of fluoroquinolone prophylaxis on neutropenic Fever, Infections, and antimicrobial resistance in newly diagnosed AML patients. Clin Lymphoma Myeloma Leuk. 2022;22(12):903\u201311.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"12026_CR35","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1182\/bloodadvances.2022008226","volume":"7","author":"D Clerici","year":"2023","unstructured":"Clerici D, Galli L, Greco R, et al. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB. Blood Adv. 2023;7(9):1621\u201334.","journal-title":"Blood Adv"},{"issue":"2","key":"12026_CR36","first-page":"61","volume":"6","author":"A Nair","year":"2023","unstructured":"Nair A, Kaundal S, Kasudhan KS, et al. Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance. Blood Cell Ther. 2023;6(2):61\u20135.","journal-title":"Blood Cell Ther"},{"issue":"6","key":"12026_CR37","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1080\/10428194.2023.2197532","volume":"64","author":"M Akhmedov","year":"2023","unstructured":"Akhmedov M, Klyasova G, Kuzmina L, et al. Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2023;64(6):1102\u201311.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"12026_CR38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cmi.2017.11.019","volume":"24","author":"M Yeshurun","year":"2018","unstructured":"Yeshurun M, Vaxman I, Shargian L, et al. Antibacterial prophylaxis with Ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous Haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. Clin Microbiol Infect. 2018;24(7):749\u201354.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"12026_CR39","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41409-020-0923-4","volume":"55","author":"AK Maurer","year":"2020","unstructured":"Maurer AK, Li S, Hunter BD, et al. Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2020;55(12):2319\u201321.","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"12026_CR40","doi-asserted-by":"publisher","first-page":"e14119","DOI":"10.1111\/tid.14119","volume":"25","author":"ES Santos","year":"2023","unstructured":"Santos ES, Lima ACM, Breda GL, et al. Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study. Transpl Infect Dis. 2023;25(5):e14119.","journal-title":"Transpl Infect Dis"},{"key":"12026_CR41","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.3748\/wjg.v20.i21.6602","volume":"20","author":"TG Gweon","year":"2014","unstructured":"Gweon TG, Choi MG, Baeg MK, et al. Hematologic diseases: high risk of clostridium difficile associated diarrhea. World J Gastroenterol. 2014;20:6602\u20137.","journal-title":"World J Gastroenterol"},{"key":"12026_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","volume":"17","author":"KE Dingle","year":"2017","unstructured":"Dingle KE, Didelot X, Quan TP, et al. Effects of control interventions on clostridium difficile infection in england: an observational study. Lancet Infect Dis. 2017;17:411\u201321.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"12026_CR43","first-page":"e1681","volume":"28","author":"H Daoud-Asfour","year":"2022","unstructured":"Daoud-Asfour H, Henig I, Ghersin I, et al. Omitting Ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and Microbiome structure. Transpl Cell Ther. 2022;28(3):e1681\u20138.","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"12026_CR44","doi-asserted-by":"publisher","first-page":"ofz252","DOI":"10.1093\/ofid\/ofz252","volume":"6","author":"M Ziegler","year":"2019","unstructured":"Ziegler M, Han JH, Landsburg D, et al. Impact of Levofloxacin for the prophylaxis of bloodstream infection on the gut Microbiome in patients with hematologic malignancy. Open Forum Infect Dis. 2019;6(7):ofz252.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12026-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:14:30Z","timestamp":1763136870000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-12026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12026"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12026-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki guidelines and received ethical approval from the Institutional Clinical Research Ethics Committee at Makassed General Hospital (approval number: 892021). Due to the retrospective design, patient consent was waived. During the data collection phase, only subject case numbers were included. At a later stage, a different number was assigned to each of our cases to safeguard subject privacy. All methods used were performed in accordance with the hospital\u2019s IRB committee guidelines and regulations. The contributing authors only performed data entry and analysis as well as the drafting of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1582"}}